Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | VRTX | REGN | GSK |
| Company | Celldex Therapeutics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 26.71 | 311.95 | 470.44 | 919.73 | 36.50 |
| High | 27.37 | 317.90 | 475.46 | 935.86 | 37.23 |
| Low | 26.14 | 310.63 | 468.47 | 914.84 | 36.28 |
| Last | 26.33 | 315.54 | 475.08 | 922.79 | 37.01 |
| Change | -0.53 | -0.46 | +4.72 | -4.54 | -1.16 |
| % Change | -1.97% | -0.15% | +1.00% | -0.49% | -3.04% |
| Volume | 669,800 | 2,220,100 | 719,400 | 628,300 | 13,419,873 |
| 20-Day Average Volume | 861,745 | 1,602,185 | 988,025 | 693,700 | 6,075,525 |
| Previous Close | 26.86 | 316.00 | 470.36 | 927.33 | 38.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.11 | 319.55 | 473.74 | 979.81 | 38.47 |
| 20-Day Raw Stochastic | 3.44% | 26.48% | 53.28% | 6.41% | 13.22% |
| 20-Day Relative Strength | 32.78% | 43.67% | 50.33% | 25.37% | 35.82% |
| Weighted Alpha | -28.88 | +14.32 | +23.53 | +2.97 | -1.29 |
| Today's Opinion | 100% Sell | 8% Buy | 40% Buy | 56% Sell | 88% Sell |
| Previous Opinion | 100% Sell | 8% Buy | 8% Buy | 40% Sell | 88% Sell |
| Last Month's Opinion | 40% Sell | 24% Buy | 8% Buy | 24% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.16% since 10/23/24 | +0.20% since 10/23/24 | +1.07% since 10/23/24 | -1.98% since 10/23/24 | -2.55% since 10/23/24 |
| Low | 26.14 on 10/30/24 | 310.63 on 10/30/24 | 468.47 on 10/30/24 | 914.84 on 10/30/24 | 36.28 on 10/30/24 |
| High | 29.38 on 10/28/24 | 320.14 on 10/28/24 | 480.41 on 10/25/24 | 952.02 on 10/24/24 | 38.26 on 10/29/24 |
| 1-Month | |||||
| %Chg | -22.54% since 09/30/24 | -2.07% since 09/30/24 | +2.15% since 09/30/24 | -12.22% since 09/30/24 | -9.47% since 09/30/24 |
| Low | 26.14 on 10/30/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 914.84 on 10/30/24 | 36.28 on 10/30/24 |
| High | 34.50 on 10/01/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 1,061.60 on 10/01/24 | 41.80 on 10/09/24 |
| 3-Month | |||||
| %Chg | -31.50% since 07/30/24 | -5.32% since 07/30/24 | -5.48% since 07/30/24 | -14.38% since 07/30/24 | -6.94% since 07/30/24 |
| Low | 26.14 on 10/30/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 914.84 on 10/30/24 | 36.28 on 10/30/24 |
| High | 47.00 on 09/25/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 44.67 on 08/27/24 |
| 6-Month | |||||
| %Chg | -29.64% since 04/30/24 | +15.19% since 04/30/24 | +20.94% since 04/30/24 | +3.61% since 04/30/24 | -10.69% since 04/30/24 |
| Low | 26.14 on 10/30/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 36.28 on 10/30/24 |
| High | 47.00 on 09/25/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,780,496 | 169,795,968 | 121,400,848 | 102,224,224 | 79,109,000 |
| Shares Outstanding, K | 66,288 | 537,329 | 258,102 | 110,235 | 2,072,544 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 2,500,000 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 9,950,400,000 |
| Last Quarter Net Income | -35,840,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,480,440,000 |
| 60-Month Beta | 1.55 | 0.61 | 0.40 | 0.12 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 08/08/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 1.09 on 07/31/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 11/04/24 | 10/31/24 | 10/30/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.385 on 08/16/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | N/A | 08/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.05 | 0.00 | 24.17 | 9.11 |